No. 24-889 |
|
Title: |
Hikma Pharmaceuticals USA Inc., et al., Petitioners v. Amarin Pharma, Inc., et al. |
Docketed: | February 19, 2025 |
Linked with: | 24A652 |
Lower Ct: | United States Court of Appeals for the Federal Circuit |
Case Numbers: | (2023-1169) |
Decision Date: | June 25, 2024 |
Rehearing Denied: | October 17, 2024 |
Dec 27 2024 | Application (24A652) to extend the time to file a petition for a writ of certiorari from January 15, 2025 to February 14, 2025, submitted to The Chief Justice. Main Document Proof of Service |
Jan 03 2025 | Application (24A652) granted by The Chief Justice extending the time to file until February 14, 2025. |
Feb 14 2025 | Petition for a writ of certiorari filed. (Response due March 21, 2025) Petition Appendix Proof of Service Certificate of Word Count |
Mar 04 2025 | Motion to extend the time to file a response from March 21, 2025 to April 21, 2025, submitted to The Clerk. Main Document |
Mar 05 2025 | Motion to extend the time to file a response is granted and the time is extended to and including April 21, 2025. |
Mar 20 2025 | Brief amici curiae of 30 Scholars of Law, Economics, and Medicine filed. Main Document Proof of Service Certificate of Word Count |
Mar 21 2025 | Brief amicus curiae of Association for Accessible Medicines filed. Main Document Certificate of Word Count Proof of Service |
Apr 04 2025 | Motion to extend the time to file a response from April 21, 2025 to May 15, 2025, submitted to The Clerk. Main Document |
Apr 07 2025 | Motion to extend the time to file a response is granted and the time is further extended to and including May 15, 2025. |
May 15 2025 | Brief of respondents Amarin Pharma, Inc., et al. in opposition filed. Main Document Certificate of Word Count Proof of Service |
Jun 02 2025 | Reply of petitioners Hikma Pharmaceuticals USA Inc., et al. filed. (Distributed) Main Document Proof of Service Certificate of Word Count |
Jun 03 2025 | DISTRIBUTED for Conference of 6/18/2025. |
Jun 23 2025 | The Solicitor General is invited to file a brief in this case expressing the views of the United States. |